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A b s t r a c t .  Background: W e  have preν iously reported that 
alkaline extract of Sasa senanensis leαν es (SE) has several 
biological activities characteristic of lignin-carbohydrate 
co m p l e x  ( L C C ) .  In the present study ,  w e  c o m p a r e d  the 
biological activ の of three commercially available products of 
S E  (products A, B  a n d  C) .  Materi α ls a n d  M e t h o d s :  Cell 
viabili η of mock-infected ,  H Iド iψ cted , UV-irradiated cells 
w a s  determined by 3 イ 4 ,5-dimethylthia zol-2-yl )-2 ,5-
diphenyltetrazalium bromide method. Radical intensity w a s  
determined by electron spin resonance spectroscopy .  
C y t o c h r o m e  P - 4 5 0  ( C Y P ) 3 A 4  activity w a s  m e a s u r e d  by (3-
hydroxylation of testosterone in h u m a n  recombinant C Y P 3 A 4 .  
Results: Product A  is a  pure S E  that contains Fe( I )-
chlorophyllin, whereα s  products B  a n d  C  contain Cu(II)-
chlorophyllin a n d  less L C C .  Product C  is supplemented with 
ginseng a n d  pine (Pin us densiflora) leaf extracts .  Product A  
exhibited 5 拘 ld higher anti-HIV, 4-fold higher anti-UV, 5-fold 
higher hydro刀 l radical-scavenging, a n d  3 内 ld lower C Y P 3 A 4  
inhibitory activities as c o m p a r e d  to those of product B, a n d  5-
fold higher, 1.5-jold higher,  comparable ， α n d  7-fold lower 
act iノ ities, respectively, as c o m p a r e d  to those of product C .  
Conclusion :  T h e  present study demonstrates for the first time 
the superiority of product A  oν er products B  a n d  C, suggesting 
the beneficial role ザ L C C a n d  Fe(ll)-chlorophyllin .  
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Alkaline 巴 xtract of the leaves of S a s a  senanensis R e h d e r  
(SE) or S a s a  albo-marginata M a k i n o  et Shibata ( S A S A -
Health⑧） ( D a i w a  Biological R e s e a r c h  Institute C o ., Ltd ., 
K a n a g a w a ,  Japan) has b e e n  r巴 cognized as over the count巴 r
( O T C )  drug effective in treating fatigue ,  l o w  appetite ,  
halitosis ,  b o d y  o d o u r  a n d  stomatitis .  T h e s e  beneficial 
clinical effects of S E  h a v e  b e e n  partiall y  supported b y  the 
following in ν itro activities :  e .g ., antiseptic (1), m e m b r a n e -
stabilising (2), anti-inflammator y  (3 5) ,  antibacterial (6 ,  7), 
anti viral (6 ,  7 ), anti-U V  (8 )  a n d  radical-sca v enging (  4 ,  7 ,  
9) activities ,  a n d  sy n巴 rgistic action with v itamin C  (6) .  
A m o n g  th巴 s巴 activities, a nti-HIV a n d  an tト U V activity ,  a n d  
synergism with v itamin C  are characteristic of lignin-
carbohydrate c o m p l巴 x (L C C )  (10) .  W e  recentl y  f o u n d  that 
nearly 7 0 %  of S E  c o m p o n e n t s  w e r巴 eluted as a  si ngle p e a k  
o n  hig ル p e r f o r m a n c e liquid c h r o m a t o g r a p h y  (H P L C ) ,  
suggesting that multiple c o m p o n e n t s  o f  S E  m a y  be 
associated with each other in the native state or after 
巴 xtraction with alkaline solution (7) .  
T h e  O T C  drugs are classified into three groups (I ,  I a n d  
I I) in Japan .  T h e  safety of O T C  drugs increases in the order 
of l<IIく I I (11) .  SE, w h i c h  belongs to G r o u p  I I, is expected to 
be I巴 s hazardous, as c o m p a r e d  with K a m p o  Medicines ,  which 
belong to G r o u p  I .  In Japan, three commercial products of S E  
(products A, B  a n d  C )  are available in drug stores. Product A  
is a  1 0 0 %  pure extract of Sasa senanensis R 巴 hder containing 
Fe(II)-chlorophyllin ,  in w h i c h  Mg(II) in th巴 centre is replaced 
b y  Fe(II) b y  adding FeC12・ Products B  and C  contain Cu(II)-
chlorophyllin a n d  l巴 sser a m o u n t  of L C C .  Product C  is 
supplemented with ginseng extract (1 .8  m g /ml) a n d  pine 
(Pinus densiflora) leaf extract (3 m g /ml) ,  with paraben as a  
preservative .  H e r e ,  w e  c o m p a r e d  the biologic al  activity of 
products A ,  B  a n d  C  for the first time. 
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T o  o u r  k n o w l e d g e  there h a s  b e e n  n o  s t u d y  that h a s  
investigated the effect o f  S E  o n  c y t o c h r o m e  P - 4 5 0  
( C Y P ) 3 A  activity. W e  recently r e p o r t e d  that the C Y P 3 A -
inhibitory activity o f  S E  ( p r o d u c t  A )  w a s  significantly 
l o w e r  t h a n  t h e  o n e  o b s e r v巴 d in grapefruit juice a n d  
chlorophyllin (7). W e  also c o m p a r e d  the thre巴 p r o d u c t s for 
their C Y P 3 A 4 - i n h i b i t o r y  activity, u s i n g  g r a p巴 juice as a  
positive control (12). 
M a t e r i a l s  a n d  M e t h o d s  
Materials. T h e  following chemicals and reagents were obtained from 
the indicated companies: D u l b巴 cco ’s modified Eagle ’S  m e d i u m  
(D M E M )  (Gibco B R L ,  G r a n d  Island ,  N Y ,  U S A ) ;  fetal bovines巴 r u m
(FBS), 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenylt巴 凶 zolium bromide 
(M T T ) ,  hypoxanthin巴 （ H X ) , xanthin巴 oxidase ( X O D ) ,  diethylenetria 
minepentaacetic acid ( D E T A P A C ) ,  5,5 dimethyl-1-pyrroline-N-oxide 
( D M P O )  (Dojin, K u m a m o t o ,  Japan); R P M I  1 6 4 0  m e d i u m ,  
azidothymidine (A Z T ) ,  2' ,3に dideoxycytidine (ddC) (Sigma Chemical 
C o .  S t. L o ui s, M O ,  U S A ) ;  dimethyl sulfoxide ( D M S O ) ,  dextran 
sulfate (5  k D a )  ( W：水 o Pure C h e m i c a l  Ind., Ltd., Osaka, Japan); 
sodiu m  ascorbate (Tokyo Chemical Industry Co., Ltd., Tokyo, Japan) ;  
curdlan sulfate (79 kDa; A j i n o m o t o  Co. Inc., Tokyo, Japan) 
P roduct A  (SE) w a s  prepar巴 d and supplied b y  D a i w a  Biological 
Research Institut巴 Co. Ltd., K a w a s a k i ,  K a n a g a w a ,  Japan .  Product B  
w a s  purchased f r o m  Sunchlon C o .  Ltd ., Ueda-shi, N a g a n o ,  Japan. 
Product C  w a s  purchased f r o m  W a k a n y a k u  Medical Institute, Ltd .,  
Shinjuku-ku ,  Tokyo, Japan. O n e  millilitre of products A ,  B a n d  C  w a s  
freeze dried to produce p o w d e r  (66.1, 77.6 and 28.5 m g ,  respectively) 
Assay for anti-HIV activity. H u m a n  T  cell leukemia virus I  ( H T L V -
I)-b巴 aring C D 4  positive h u m a n  T  c巴 I line, M T - 4  cells, w e r e  
cultur巴 d i n R P M I  1640 m e d i u m  supplemented with 1 0 %  F B S  and 
infected with HIV-lurn at a  multiplicity of infection of 0 .01. H I V -
and mock-infected (control) M T - 4  cells (3 × [Q4 cells/96-microwell) 
w e re  incubated for five days with different concentrations of product 
samples and the relative viabl巴 cell n u m b e r  w a s  determined b y  M τ T  
assay. T h e  concentration that reduced the viable cell n u m b e r  of the 
uninfected cells b y  5 0 %  (CC50) a n d  the concentration that increased 
the viable cell n u m b巴 r of the HIV-infected c巴 l s u p  to the 5 0 %  
c o m p a r e d  to the o n e  of control (mock-infected, untreated) cells 
(EC50), w e r e  determined f r o m  the dos巴ー r巴 sponse curve with m o c k -
infected and HIV-infected cells, respectively. T h e  anti-HIV activity 
w a s  evaluated b y  the selectivity index (SI), w h i c h  w a s  calculated 
using the following equation: S I = C C s olE C 5 o  (13) 
Assay o f  anti-UV actiνity. H S C - 2  c巴 !ls (provided b y  Prof. N a g u m o ,  
S h o w a  University) were inoculated into 96-microwell plates (3 × 103 
cells/well, 0.1 ml/well) a n d  incubated for 4 8  hours to allow cel  
attachment. T h e  culture supernatant w a s  replaced with lOO μI 
phosphate buffered saline without calcium and m a g n e s i u m  [ P B S （一）］
出 at contained different concentrations of products, plac巴 d at 21 c m  
distance from a  U V  lamp (wavelength: 253.7 n m )  a n d  exposed to U V  
irradiation (6 J/m2/min) for I  min. T h e  cells w e r e  then incubated for 
a  further 4 8  hours in D M E M  containing l 0 %  F B S  to determine 出 e
relative viab le  cel  n u m b e r  b y  the M T T  assay. F r o m  the dose-response 
curve, the C C 5 0  and the concentration that increased th巴 viability of 
UV-irradiated cells u p  to 5 0 %  c o m p a r e d  to that of control 
(  unirradiat巴 d , untreated) cells (EC50) w e r e  determined. T h巴 SI w a s  
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determined using the following equation: S I = C C 5 0/E C 50  (1 4 ,  15). 
Radical-scavenging activity. T h e  free radical intensity  w a s  
det巴 r m i n e d at 2 5 ° C ,  using electron spin resonance (E S R )  
spectroscopy ( J E O L  J E S  R E I X ,  X - b a n d ,  1 0 0  k H z  modulation 
frequency ,  J E O L  Ltd., Tokyo, Japan) (16). T h e  instrument settings 
were: centre field, 335.5 ±  5.0 m T ;  m i c r o w a v e  p o w e r ,  16 m W ;  
modulation amplitude, 0.1 m T :  gain, 630; time constant ,  0.03 s a n d  
scanning time, 2  min. 
For th巴 determination of the superoxide anion (in the f o r m  of 
D M P O - O O H ),  produced b y  the H X - X O D  reaction (total volume: 
2 0 0 凶） [2 m M  H X  in 0.1 M  phosphate buffer (PB) ( p H  7 .4 )  5 0  μl, 
0.5 m M  D E T A P A C  2 0  μl, 8 %  D M P O  3 0  μI, sample (in P B )  4 0  μI ,  
P B  3 0  μl ,  X O D  (0.5 U / m l  in P B )  3 0  μl], the time constant w a s  
c h a n g巴 d to 0.03 s  (16). 
F o r  the determination o f  th巴 hydroxyl radical (in the f o r m  of 
D M P O  O H ) ,  p r o d u c e d  b y  the Fenton reaction (200 μl) (1 m M  
F巴 S 0 4 (containing 0.2 m M  D E T A P A C )  5 0  μI, 0.1 M  P B  ( p H  7.4) 
5 0  μI, 9 2  m M  D M P O  2 0  μl, sample (in H 2 0 )  5 0  μl, l  m M  H 2 0 2 ,  
3 0  μl], the gain w a s  c h a n g e d  to 160 (16). 
T h e  concentration that reduced the radical intensity o f  D M P O -
O O H  a n d  D M P O - O H  b y  5 0 %  (IC50)  w a s  determined b y  the dose-
response curve. 
M e a s u r e m e n t  o f  C Y P 3 A 4  activiり 人 C Y P 3 A 4 activity w a s  measured b y  
B-hydroxylation of t巴 stosteron巴 in h u m a n  recombinant C Y P 3 A 4  
(Cypex Ltd., Dundee, U.K.). T h e  reaction mixture, containing 2 0 0  m M  
potassium phosphate buffer ( p H  7.4) ,  N A D P H  regenerating system 
(  1.3 m M  N A D P H ,  1.3 m M  glucose-6-phosphate, 0.2 U / m l  glucose-6-
phosphate d巴 hydrogenase ,and 3.3 m M  M g C l 2 )  along with 0, O.Ql, 0.1, 
0.5 ,  l.O and 2 %  of 出 e product samples or vehicle ( D M S O )  and the 
h u m a n  recombinant C Y P 3 A 4  (16.5 pmol/ml) ,  w a s  preincubat巴 d at 
3 7 ° C  for 2  m i n .  T h e  reaction w a s  started b y  the addition of 3 0 0 ド M
testosterone substrat巴 s. T h e  final volume of the reaction mixture w a s  
2 5 0  μl with a  final D M S O  concentration of 2 % .  T h e  reaction w a s  
stopped b y  the addition of 5 0 0  μl ethyl ac巴 tate after 15 m i n .  After 
centrifugation (15,000 × g ,  5  min), 4 0 0 凶 of supernatant w a s  collected ,  
dried ,  a n d  resuspended in 2 0 0  μl of methanol. Anal y ses of the 
metabolites were perfo口 n e d b y  H P L C  ( J A S C O  P U 2 0 8 9 ,  A S 2 0 5 7 ,  
U V 2 0 7 5 ,  C h r o m N A V )  equipped with T S K  gel O D S - 1 2 0 A ,  4.6 m m  
I D× 2 5  c m ,  5  μ m  c o l u m n  ( T O S O H ,  Tokyo, Japan). T h e  mobile phase 
consisted of 7 0 %  methanol and 3 0 %  water. T h e  metabolites w e r e  
separated using an isocratic m e t h o d  at a  flow rate of 1.0 m l/m i n  
Quantification of the metabolites w a s  performed b y  comparing the 
H P L C  peak area at 2 5 4  n m  to the o n e  of l  l α p r o g巴 sterone, the 
internal standard. T h e  retention times for 6B-hydroxytestosterone and 
1  lα － progesterone w e r e  appro氾 mately 5.0 and 6 .7  min, resp巴 ctively.
T h e  conc巴 ntration that inhibit巴 d th巴 C Y P 3 A 4 activity by 5 0 %  (IC50) 
w a s  det巴 rrnin巴 d f r o m  the dose-respons巴 curve
Statistical analysis. Experimental values w e r e  expressed as the 
m 巴 an±standard deviation (SD). Statistical analysis w a s  performed 
b y  using Student’s  t-test. A  p-value <0.05 w a s  considered to b e  
significant. 
R回 ults
A n t i - H I V  actiν ity. P r o d u c t s  A ,  B  a n d  C  al  ef i巴 ctively d o s e -
d e p e n d e n t l y  r e d u c e d  the cytopathic effect o f  H I V  infection 
(closed s y m b o l s  in F i g u r e  1), a l t h o u g h  their a n t i - H I V  activity 
R a d i c a l - s c a v e n g i n g  acti ν ity. P r o d u c t s  A ,  B  a n d  C  d o s e -
d e p e n d e n t l y  r e d u c e d  the intensity o f  s u p e r o x i d e  a n i o n  ( 0 2  -) 
(detected as D M P O - O O H )  g e n e r a t e d  b y  H X  a n d  X O D  
reaction ( F i g u r e  3 A ) .  T h e  p o t e n c y  o f  0 2  s c a v e n g i n g  
activity o f  the three p r o d u c t s  w a s  c o m p a r a b l e :  p r o d u c t  A  
( I C 5 0 = 0 . 4 6  m g / m l ) ,  p r o d u c t  B  ( I C 5 0 = 0 . 5 2  m g / m l )  a n d  
p r o d u c t  C  ( I C 5 0 = 0 . 5 4  m g / m l )  (Table I I) .  
P r o d u c t s  A ,  B  a n d  C  d o s e - d e p e n d e n t l y  r e d u c e d  th巴
intensity o f  h y d r o x y l  radical （・ O H ) (detected as D M P O - O H )  
generat巴 d b y  the F e n t o n  reaction (Figure 3B). T h e  p o t e n c y  
R e p e a t e d 巴 x p e r i m e n t g a v e  a  similar order o f  p o t e n c y  o f  thes巴
p r o d u c t s  [product A  ( S I = 2 1 . 1 )  > p r o d u c t  C  ( S I = > l 2 . 4 )  
> p r o d u c t  B  (SI=5.l)] ( E x p .  I , T a b l e  I ) .  T h e  a n t i - U V  activity 
o f  p r o d u c t  A  w a s  a p p r o x i m a t e l y  5 9 %  o f  that o f  v i t a m i n  C  
(SI=33.2), as positiv巴 control (Table I ). 
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CC50. 5 0 %  Cytotoxic concentration; E C 5 0：・ 5 0 % e百 ective concentration; 
SI: selectivity index .  
Table I .  A m i  U V  activi砂 of three commercial products of Sasa senanensts 
R e h d e r  extract. E a c h  νalue w a s  determined f r o m  the dose-response curve 
with triplicate assay in experiments I  a n d  fl (Figure 2). 
Table I. A n t i - H I V  actiν ity o f  three c o m m e rcial products o f  S a s a  
senanensis R e h d e r  extract. E α ch value w a s  determined f r o m  the dose-
response cur νe in Figure I  
CC50: 5 0 %  Cytotoxic concentration; EC50. 5 0 %  e仔 ective concen位 at1on;
SI: selectivity index; DS: dextran sulfate, C R D S :  curdlan sulfate, A Z T :  
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Test material 
A n t i - U V  activi η. W e  recently reported that U V  irradiat10n 
i n d u c e d  n o n - a p o p t o t i c  cell d e a t h  in H S C - 2  cells, w i t h o u t  
induction o f  caspase-3 activation a n d  i n t e m u c l e o s o m a l  D N A  
f r a g m巴 ntation (14). P r o d u c t s  A ,  B  a n d  C a l l  d o s e - d e p e n d巴 ntly
r e d u c e d  U V - i n d u c e d  cytotoxicity (Figure 2). T h e  p o t e n c y  o f  
a n t i - U V  activity w a s  in the o r d e r  o f  p r o d u c t  A  ( S I = l 8 . 4 )  
> p r o d u c t  C  (SI=12.6) > p r o d u c t  B  (SI=3.7) (Exp. I, T a b l e  I ). 
w a s  m u c h  l o w e r  than th巴 o n e o f  the positive controls [dextran 
sulfate ( S I = l 3 7 8 ) ,  curdlan sulfate ( S I = 5 6 0 6 ) ,  a z i d o t h y m i d i n e  
( S I = 1 7 7 4 6 ) ,  2 ’ 3’－ dideoxycytidine ( S I = S  123)] (Table I). T h e  
p o t e n c y  o f  a n t i - H I V  activity w a s  in the order o f  p r o d u c t  A  
( S I = 6 0 7 )  > p r o d u c t  C  ( S I = l l 7 )  > p r o d u c t  B  (SI=lll). 
Figure 1  A n t i - H I V  activity of three co m m e r c i a l  products of S a s a  
senanensis R e h d e r  extract. H I V - I  ms-infected ( H I V + )  a n d  m o c k  infected 
(HIV-) M T - 4  cells were incubated for 5  days with the indicated 
concentrations o f  products A  (upper panel), B  (center panel) a n d  C  
(lower pα nel) a n d  the viable cell n u m b e r  w a s  determined b y  the M T T  
assay a n d  expressed as a  percentage that of the control. D a t a  represent 
the m e a n ± s t a n d a r d  de νiationfrom triplicate assays. ft should be noted 
that product C  exhibited a  w e a k  cytostatic ξ ffect at lower concentrations 
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Figure 2. Anti U V  activity o f  three commercial products o f  S a s a  senanensis R e h d e r  extract. H S C - 2  cells w e r e  exposed ( U V + )  or not ( U V - )  to U V  
irradiα tion (6 Jlm2/min) for 1  m i n  in P B S ( - )  containing the indicated concentration.< o f  products A  (upper panel), B  (center panel), a n d  C  (lo w e r  
panel), a n d  then w e r e  cultured for 4 8  hours. Viable cell n u m b e r  w a s  then determined b y  M I T  assay a n d  eχ pressed as a  percentage that of the control 
(non-irradiated a n d  incubated without S E). Experiments w e陀 performed twice (Exps. I  a n d  I ),  a n d  each ν・alue rep陀 sents the m e a n ± S . D .  o f  triplicate 
assays. It should b e  noted that product C  exhibited a  w e a k  cytostatic effect at lower concentra tions (indicated by dotted area). SI: selectivity index. 
of products A  a n d  C  w a s  c o m p a r a b l e  with each other 
(IC50=2.l a n d  1.9 m g / m l ,  respectively), but 4-fold higher 
than that of product B  (IC50=8.0 m g / m l )  (Table I I) .  
C Y P 3 A 4 - i n h i b i t o r y  activity. Products A ,  B  a n d  C  dose-
dependently inh耐 ted the 。－ hydroxylation of 回 tosterone,
generally used for the assay of C Y P 3 A 4  activity (Figure 4  and 
Table IV). Product C  exhibited the highest CYP3A4-inhibitory 
activity (IC50=58 μg/ml), followed b y  product B  (IC50= 124 
μg/ml) a n d  then product A  (IC50=403 μg/ml) .  Product B  
inhibited the C Y P 3 A 4  to an extent similar to that attained b y  
Cu(II)- chlorophyllin (7); product A  inhibited C Y P 3 A 4  to 
lower extent than that achieved b y  grapefruit juice (7). 
D i s c u s s i o n  
T h e  present study demonstrated for the first tim巴 that al  
three S E  products exhibited potent anti-HIV, a n t i - U V  a n d  
radical-scavenging activity. All these data are s u m m a r i z e d  in 
Table V. Product A  w a s  found to have 4  to 5-fold higher anti-
H I V ,  anti-UV a n d  ・O H radical-scavenging activity as 
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c o m p a r e d  with product B. This suggests the beneficial role 
of L C C  a n d  F 巴（ II)-chlorophyllin. Product C  w a s  f o u n d  to 
h a v e  m u c h  higher biological activity than product B ,  
possibly d u e  to the supplementation of gins巴 n g a n d  pine 
( P i n u s  d e n s i f l o r a )  leaf extracts, but the potency of product 
C  w a s  stil  less than that of product A .  
T h e  present study also demonstrated that the C Y P 3 A 4  
inhibitory activity of product C  w a s  nearly 7 -fold higher 
c o m p a r e d  to the o n巴 of product A .  This suggests that 
product C  m a y  better e n h a n c e  the bioavailability of drugs 
(especially, C Y P 3 A  substrates) that are administered 
together with it, as c o m p a r e d  with product A ,  a n d  thus it is 
important to perform therapeutic drug monitoring of product 
C  to m i n i m i z e  the possible side-effects of an a c c o m p a n y i n g  
drug that is metabolized b y  C Y P 3 A .  It should be noted that 
lower concentrations of product C  (0.02-2.5%) exhibit巴 d
slight, but reproducible cytotostatic activity (indicated b y  
dotted circles in Figures 1  a n d  2) .  Further experiments 紅 e
required to identify the cytostatic principle (whether it is the 
e x o g e n o u s  plant extracts or preservativ巴）. All data suggest 
the superiority of product A  over products B  a n d  C. 
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Figure 4 .  C Y P 3 A 4  inhibitory activ の of products A, B  a n d  C. E a c h  νalue 
represents the m e a n孟 S D . o f  triplicate assays. * p < 0 . 0 5  relative to the 
control (0%). 
Table I V  C Y P 3 A 4  inhibitory activity of three c o m m e r c i a l  products o f  
S a s a  senanensis R e h d e r  extract. E a c h  value w a s  calculated f r o m  the 


















可コ n  










C Y P 3 A 4  inhibition (IC5o) 
0 . 6 1 %  (403 μg/ml) 
0 . 1 6 %  (124 μg/ml) 
0 . 2 0 %  (58 μg/ml) 
0 . 9 9 %  (576 μg/ml) 
109 μg / m l  
0 . 4 9 %  
Reference substances [see (7)] 
Product A  
C u  (I ) chlorophyllm 
Grapefruit juice 
Product A  
Product B  
Product C  
C o n c e n t r a t i o n ( % )  
Figure 3. Effect o f  products A, B  a n d  C  o n  the radical intens 旬 。 f
superoxide anion radical, m e a s u r e d  as D M P O - O O H  p r o d u c e d  b y  
hypoxanthine-xanthine oxidase reaction (A) a n d  hydroxyl radical, 
m e a s u r e d  as D M P O  O H  p r o d u c e d  by Fenton reaction (B). E a c h  νalue 
represents the m e a n ± S D .  of triplicate assays. *pく 0 .05 relative to the 
control ( 0 % )  
Table I I. Radical scaν enging activity of three commercial products of 
Sas a  senanensis R e h d e r  extract. E a c h  value w a s  ca lculated f r o m  the 
data of Fi伊 tre 3  
IC50: T h e  concentration that inhibits the C Y P 3 A 4  activity by 5 0 % .  




Table V. S u m m a r y  of biological activities of three S E  products 
Relative biological activity 
( %  of product A )  
3 . 2 %  (2.l m g /ml) 
10.3% (8.0 m g /ml) 
6 . 6 %  (1.9 m g /ml) 
0 . 6 9 %  (0.46 m g /ml) 
0 . 6 7 %  (0.52 m g /ml) 
1.9% (0.54 m g/ml) 
Product A  
Product B  
Product C  
Product C  Product B  Product A  
IC50: T h e  concentration that reduced the radical intensity by 5 0 % .  
activity t o g e t h e r  w i t h  the antioxidant a n d  the anti-
i n f l a m m a t o r y  activity o f  p r o d u c t  A  s u g g e s t  its possible 
applicability to the p r e v e n t i o n  o f  o r  t h e r a p y  for virally 
m e d i a t e d  diseases. 























• O H - S c a v e n g i n g  activity 
CYP3A4-inhibitory activity 
S u p p l e m e n t a t i o n  o f  g i n s e n g  a n d  p i n e  ( P i n u s  densiflora) leaf 
extracts c a n n o t  c o m p e n s a t e  for the loss o f  L C C  
( u n p u b l i s h e d  data), indicating that the p u r巴 S E is sufficient 
a l o n e  for e x p r e s s i n g  its full biological activity, a n d  the 
effects o f  a n y  m a n i p u l a t i o n  ( s u c h  as r e m o v a l  o f  L C C )  a n d  
s u p p l e m e n t a t i o n  w i t h  o t h e r  plant extracts s h o u l d  b e  
carefully considered. 
P r o d u c t  A  h a d  m u c h  h i g h e r  a n t i - H I V  activity ( S I = 6 3 9 )  as 
c o m p a r e d  w i t h  tric in  ( S I = 2 7 ) ,  a  p o t e n t  a n t i - h u m a n  
c y t o m e g a l o v i r u s  a g e n t  (17), a n d  luteolin g l y c o s i d e s  (  18) 
( S I = 2～ 7) f r o m  S a s a  s e n a n e n s i s  R e h d e r .  T h e  potent anti-viral 
i n  v i v o  26: 2 5 9嶋 2 6 4 (2012) 
A l t h o u g h  O T C  drugs, c a t e g o r i z e d  as G r o u p  III, are the 
least h a z a r d o u s ,  it m a y  b e  preferable to test their safety 
b e f o r e  m a r k e t i n g ,  u s i n g  in ν itro biological a s s a y  s y s t e m s  
s u c h  as the o n e s  that are d巴 scribed in this study. 
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